Who owns XILIO THERAPEUTICS INC?
- Ticker: XLO
- CUSIP Number: 98422t100
Tip: Access positions for across all investors
Analyze quarterly positions in Xilio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xilio Therapeutics stock
Who bought or sold XILIO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Gilead Sciences | 9.1M | $7.7M | 0% | Sep 2025 |
|
| Bain Capital Life Sciences Investors | 4.6M | $3.8M | 0% | Sep 2025 |
|
| Merck & Co | 1.5M | $1.3M | 0% | Sep 2025 |
|
| Takeda Pharmaceutical | 1.5M | $1.2M | 0% | Sep 2025 |
|
| Vanguard Group | 1.3M | $804k | 0% | Dec 2025 |
|
| AJU IB Investment | 668k | $596k | 0% | Sep 2025 |
|
| FMR | 512k | $431k | 0% | Sep 2025 |
|
| Renaissance Technologies | 344k | $221k | 68% | Dec 2025 |
|
| Geode Capital Management | 329k | $211k | 0% | Dec 2025 |
|
| Squarepoint Ops | 329k | $277k | 40% | Sep 2025 |
|
| Trustees of Columbia University in the City of New York | 250k | $210k | 0% | Sep 2025 |
|
| Balyasny Asset Management | 199k | $168k | 0% | Sep 2025 |
|
| State Street Corporation | 186k | $119k | 14% | Dec 2025 |
|
| GSA Capital Partners | 148k | $95k | 100% | Dec 2025 |
|
| Stonepine Capital Management | 126k | $81k | 100% | Dec 2025 |
|
| Two Sigma Investments | 88k | $74k | 13% | Sep 2025 |
|
| XTX Topco | 76k | $64k | 119% | Sep 2025 |
|
| Northern Trust | 67k | $56k | 0% | Sep 2025 |
|
| Bridgeway Capital Management | 56k | $47k | 0% | Sep 2025 |
|
| Two Sigma Securities | 32k | $27k | 100% | Sep 2025 |
|
| Two Sigma Advisers | 30k | $25k | 100% | Sep 2025 |
|
| Mariner Wealth Advisors | 25k | $16k | 0% | Dec 2025 |
|
| Aptus Capital Advisors | 25k | $21k | 0% | Sep 2025 |
|
| Hrt Financial | 25k | $20k | 100% | Sep 2025 |
|
| LPL Financial | 21k | $13k | -32% | Dec 2025 |
|
| Raymond James Financial | 19k | $16k | 0% | Sep 2025 |
|
| Dunhill Financial | 10k | $6.6k | 0% | Dec 2025 |
|
| Pinnacle Financial Group, LLC / IL | 10k | $8.4k | 0% | Sep 2025 |
|
| Investors Asset Management Of Georgia | 10k | $6.4k | 0% | Dec 2025 |
|
| Federation des caisses Desjardins du Quebec | 3.3k | $2.8k | 0% | Sep 2025 |
|
| BlackRock | 2.0k | $1.7k | 0% | Sep 2025 |
|
| Key FInancial | 830.00 | $531.034000 | 0% | Dec 2025 |
|
| Private Wealth Management Group | 310.00 | $198.989000 | 0% | Dec 2025 |
|
| UBS Group | 203.00 | $130.001200 | -99% | Dec 2025 |
|
Who sold out of Xilio Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ghisallo Capital Management | Jun 2025 | 1.3M | $906k |
| Honkamp Krueger Financial Services | Jun 2025 | 142k | $97k |
| SevenBridge Financial | Sep 2025 | 25k | $19k |
| Tower Research Capital | Jun 2025 | 15k | $11k |